Survival Among Patients With High-Risk Gastrointestinal Cancers During the COVID-19 Pandemic.

ABSTRACT:

Importance

Prior reports demonstrated that patients with cancer experienced worse outcomes from pandemic-related stressors and COVID-19 infection. Patients with certain malignant neoplasms, such as high-risk gastrointestinal (HRGI) cancers, may have been particularly affected.

Objective

To evaluate disruptions in care and outcomes among patients with HRGI cancers during the COVID-19 pandemic, assessing for signs of long-term changes in populations and survival.

Design, setting, and participants

This retrospective cohort study used data from the National Cancer Database to identify patients with HRGI cancer (esophageal, gastric, primary liver, or pancreatic) diagnosed between January 1, 2018, and December 31, 2020. Data were analyzed between August 23 and September 4,

SUBMITTER: Janczewski LM 

PROVIDER: S-EPMC10915687 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature